TFX
Teleflex Incorporated
NYSE · Healthcare · Medical - Instruments & Supplies · US
$138.36
−1.14%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.6B | 2.0B | 3.0B | 3.0B | 2.8B |
| Cost of Revenue | 1.2B | 872.0M | 1.3B | 1.3B | 1.3B |
| Gross Profit | 1.4B | 1.1B | 1.7B | 1.6B | 1.5B |
| Operating Expenses | |||||
| R&D Expense | 195.5M | 144.8M | 161.7M | 154.4M | 153.8M |
| SG&A Expense | 943.7M | 720.2M | 995.3M | 929.9M | 863.7M |
| General & Admin Expense | 213.5M | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 172.0M | — | 394.7M | 56.4M | 13.8M |
| Total Operating Expenses | 1.3B | 865.0M | 1.6B | 1.1B | 1.0B |
| Cost and Expenses | 2.5B | 1.7B | 2.9B | 2.5B | 2.3B |
| Operating Income (EBIT) | 87.1M | 255.8M | 151.0M | 506.3M | 499.7M |
| Non-Operating | |||||
| Interest Income | 7.1M | 6.4M | 8.0M | 12.8M | 912.0K |
| Interest Expense | 119.4M | 100.2M | 83.5M | 85.1M | 54.3M |
| Net Interest Income | (112.3M) | (93.8M) | (75.5M) | (72.3M) | (53.4M) |
| Other Non-Op Income/Expense | (496.8M) | (231.3M) | (75.5M) | (72.3M) | (53.8M) |
| Non-Operating Income (excl Interest) | 427.1M | 131.0M | (8.0M) | (12.8M) | (458.0K) |
| EBT (Pre-Tax Income) | (409.7M) | 24.6M | 75.5M | 434.0M | 445.9M |
| Income Tax Expense | (34.2M) | (34.0M) | 5.3M | 76.4M | 83.0M |
| Bottom Line | |||||
| Net Income | (1.0B) | (905.6M) | 69.7M | 356.3M | 363.1M |
| Earnings from Cont. Ops | (375.5M) | 58.5M | 70.2M | 357.6M | 362.9M |
| Earnings from Discont. Ops | (653.9M) | (964.2M) | (487.0K) | (1.2M) | 223.0K |
| Bottom Line Net Income | (1.0B) | (905.6M) | 69.7M | 356.3M | 363.1M |
| Per Share | |||||
| Basic EPS | ($23.28) | ($20.30) | $1.49 | $7.58 | $7.74 |
| Diluted EPS | ($23.29) | ($20.25) | $1.48 | $7.53 | $7.68 |
| Revenue Per Share | $59.70 | $44.66 | $65.06 | $63.31 | $59.51 |
| Shares | |||||
| Basic Shares Outstanding | 43.6M | 44.6M | 46.8M | 47.0M | 46.9M |
| Diluted Shares Outstanding | 43.7M | 44.7M | 47.1M | 47.3M | 47.3M |
| Profitability Metrics | |||||
| EBITDA | (238.0M) | 302.5M | 433.6M | 761.2M | 730.8M |
| D&A | 101.9M | 177.7M | 274.6M | 242.1M | 230.6M |
| EBIT | (340.0M) | 124.8M | 159.0M | 519.1M | 500.2M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026